Trial Profile
A Pharmacodynamic Study of Pre-Prostatectomy Rapamycin [sirolimus] in Men With Advanced Localized Prostate Cancer
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Sirolimus (Primary)
- Indications Adenocarcinoma; Prostate cancer
- Focus Pharmacodynamics
- 19 Feb 2019 Status changed from active, no longer recruiting to completed.
- 14 Apr 2009 Planned number of patients changed from 42 to 60 as reported by ClinicalTrials.gov.
- 14 Apr 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.